CAD, or computer-aided design, has transformed design in many fields, allowing simulation and numerical data modeling in industries such as architecture, engineering, construction, product design and ...

Optibrium, a leading developer of software and AI solutions for drug discovery, today announced the acquisition of BioPharmics LLC, expanding its 3D drug design and modelling offering. Bringing ...

Ottawa, Oct. 09, 2025 (GLOBE NEWSWIRE) -- The global computer-aided drug design (CADD) market is experiencing rapid growth, projected to generate hundreds of millions in revenue between 2025 and 2034.

The drug development pipeline is a costly and lengthy process. Identifying high-quality "hit" compounds—those with high potency, selectivity, and favorable metabolic properties—at the earliest stages ...